This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Halsted's theory

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Halsted proposed that breast cancer cells spread from the primary tumour to the first node in the lymphatic chain. At this point they were impeded by a filtering mechanism. Once the first node was overwhelmed with local deposit, only then could the tumour pass onwards to the next lymph node in the regional chain. Consequently, Halsted deemed that radical resection of all the regional lymphatic drainage was necessary for complete eradication of the tumour.

In support of this theory:

  • clinically, the natural history of most breast cancer seems to involve a sequential progression of involvement of the nodes along a regional chain
  • in a large minority, radical resection of regional lymphatics in women with axillary node disease does seem to prevent recurrence
  • tumour emboli - the basis of the alternative theory - have not been demonstrated in the clinical setting

However, against Halsted's theory are:

  • radical surgery does not improve patient survival
  • animal models show that lymph nodes may not filter tumour cells and this is supported by histological studies which show lymphatic bypass channels around nodes

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.